随着免疫学的发展,卡介苗(BCG)不仅作为特异性免疫预防结核病的重要手段,而且已在临床作为非特异性免疫疗法得到广泛应用。用活卡介苗作为非特异性免疫疗法,首用于治疗白血病(已有近十年历史)。随着免疫学的进展,目前认为卡介苗作为非特异性免疫疗法,仍是应用最广泛的方法之一。随着实践 With the development of immunology, BCG is not only used as an important means to prevent tuberculosis through specific immunity, but also has been widely used as a non-specific immunotherapy in the clinic. Live BCG is used as a non-specific immunotherapy and is first used for the treatment of leukemia (almost a decade old). With the development of immunology, BCG is currently considered as one of the most widely used methods as a non-specific immunotherapy. With practice